Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AND017 for Anemia in Dialysis-Dependent Chronic Kidney Disease
NCT07494409Phase 3Recruiting
- Sponsor
- Kind Pharmaceuticals LLC
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AND017 in anemia due to chronic kidney disease, sponsored by Kind Pharmaceuticals LLC. Started Oct 2025; status: recruiting.
02
Drugs
AND017
03
Conditions
anemia due to chronic kidney disease
Beyond the preview
Go deeper on NCT07494409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07494409.